Funding Secured from the Bill & Melinda Gates Foundation Focuses on Developing Next Generation Device for Long-Term Therapy Delivery    ...

Ashland, MA; September 16, 2024 – Takeda Pharmaceutical Company Limited has returned to BioSurfaces the exclusive rights in BioSurfaces’...

BioSurfaces is excited to announce that Mark Guitarini will be joining its Business Advisory Board. Mr. Guitarini is a seasoned strategic...

Ashland Business Recognized at Annual Manufacturing Award Ceremony Boston, MA – The Massachusetts Legislature’s Manufacturing Caucus...

BioSurfaces has been trying to expand it's Bio-Spun™ scaffolds into the organ-on-chip market and have worked with Finnadvance to begin...

Food and Drug Administration (FDA) Modernization Act 2.0 – What It Means and The Role for Bio-Spun™ 3D Scaffold Technology President...

BioSurfaces Receives $1.72 Million Small Business Innovation Research (SBIR) Direct Phase II Grant from National Institutes of Health...

Jean Angus Joins BioSurfaces Business Advisory Board Release Date: February 16, 2023 BioSurfaces is pleased to announce Jean Angus has...

BioSurfaces Receives Strategic Investment from Saint-Gobain BioSurfaces to Advance Technology and Expand Manufacturing Capabilities...

Release Date: April 8, 2022 BioSurfaces is pleased to announce Ben Dunn and John Brooks III have joined the company’s Business Advisory...